Fluid Management in Cardiac Surgery: Is One Hydroxyethyl Starch Solution Safer Than Another?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 6, 2006, Pages 916-917

  Haynes, Gary R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; FLUID THERAPY; GLOMERULAR DYSFUNCTION; HEART SURGERY; HUMAN; KIDNEY DYSFUNCTION; LETTER; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PRURITUS; SAFETY;

BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; GELATIN; HETASTARCH; HUMANS; PLASMA SUBSTITUTES; POSTOPERATIVE HEMORRHAGE; RENAL INSUFFICIENCY;

EID: 33751324135     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.04.011     Document Type: Letter

References (22)

1. Boldt J. Volume therapy in cardiac surgery: Are Americans different from Europeans?. J Cardiothorac Vasc Anesth 20 (2006) 98-105
2. Haynes G.R., Havidich J.E., and Payne K.J. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology 101 (2004) 560-561
3. Avorn J., Patel M., Levin R., et al. Hetastarch and bleeding complications after coronary artery surgery. Chest 124 (2003) 1437-1442
4. Winkelmayer W.C., Glynn R.J., Levin R., et al. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64 (2003) 1046-1049
5. Sedrakyan A., Gondek K., Paltiel D., et al. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 123 (2003) 1853-1857
6. Trowbridge C.C., Stammers A.H., Wood G.C., et al. Improved outcomes during cardiac surgery: A multifactorial enhancement of cardiopulmonary bypass techniques. J Extra Corpor Technol 37 (2005) 165-172
7. Kasper S.M., Meinert P., Kampe S., et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99 (2003) 42-47
8. Keyser E.J., Latter D.A., Morin J.E., et al. Pentastarch versus albumin in cardiopulmonary bypass prime: Impact on blood loss. J Card Surg 14 (1999) 279-286
9. Tabuchi N., de Haan J., Gallandat Huet R.C., et al. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 74 (1995) 1447-1451
10. US Food and Drug Administration. Gelatin. Federal Register 43 (1978) 14743
11. Haisch G., Boldt J., Krebs C., et al. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth 15 (2001) 316-321
12. Boldt J., Brenner T., Lehmann A., et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin. Intensive Care Med 29 (2003) 763-769
13. Boldt J., Knothe C., Zickmann B., et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 76 (1993) 1185-1190
14. Tigchelaar I., Gallandat Huet R.C., Korsten J., et al. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 11 (1997) 626-632
15. Wiedermann C.J. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch. Intensive Care Med 30 (2004) 519-520 author reply 521
16. Jamnicki M., Zollinger A., Seifert B., et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 87 (1998) 989-993
17. Waitzinger J., Bepperling F., Pabst G., et al. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs R D 4 (2003) 149-157
18. Bork K. Pruritus precipitated by hydroxyethyl starch: A review. Br J Dermatol 152 (2005) 3-12
19. Morgan P.W., and Berridge J.C. Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery. Br J Anaesth 85 (2000) 696-699
20. Barron M.E., Wilkes M.M., and Navickis R.J. A systematic review of the comparative safety of colloids. Arch Surg 139 (2004) 552-563
21. Wiedermann C.J. Hydroxyethyl starch-Can the safety problems be ignored?. Wien Klin Wochenschr 116 (2004) 583-594
22. Herwaldt L.A., Swartzendruber S.K., Edmond M.B., et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 19 (1998) 9-16